top of page

FDA to Warn J&J Vaccine Can IncreaseGuillain-Barré Risk: Media

Medscape News :

People receiving the Johnson and Johnson COVID-19 vaccine could be at increased risk for developing Guillain-Barré syndrome, the US Food and Drug Administration (FDA) is expected to announce as early as tomorrow, according to multiple media reports.

Although the FDA is projected to add the new warning to the labeling for the vaccine, the agency still calculates the benefit of vaccination with the J&J product continues to outweigh the risk. Benefits include protection against the Delta variant and serious COVID-19 outcomes.

More than 100 cases of Guillain-Barré reported to the Vaccine Adverse Event Reporting System, a federal program for reporting vaccine issues, spurred the FDA to act.

Read more here : https://www.medscape.com/viewarticle/954669?src=mkm_covid_update_210712_MSCPEDIT&uac=218819SG&impID=3501374&faf=1

2 views0 comments

Recent Posts

See All

Commentaires


bottom of page